Inspiration

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inspire Medical Systems, Inc. - INSP

Retrieved on: 
Tuesday, January 2, 2024
LLP, News, Inspiration, Pomerantz, Prior, Patient, Pharmaceutical industry

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).

Key Points: 
  • NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).
  • The investigation concerns whether Inspire Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Inspire Medical Systems, Inc. (INSP) Investors

Retrieved on: 
Tuesday, January 2, 2024
Class Action Lawsuit, Professional Services, Legal, Telephone, Suite, News, Inspiration, Law, OSA, Defendant

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP ) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).

Key Points: 
  • Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP ) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
  • Inspire Medical investors have until February 20, 2024 to file a lead plaintiff motion.
  • Investors suffering losses on their Inspire Medical investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .
  • On this news, Inspire Medical’s stock price fell $31.79, or 19.8%, to close at $129.65 per share on November 8, 2023, thereby injuring investors.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Inspire Medical Systems, Inc. (INSP) Investors

Retrieved on: 
Tuesday, January 2, 2024
Class Action Lawsuit, Professional Services, Legal, Suite, Person, Court, News, Inspiration, Law, OSA, Defendant

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP ) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).

Key Points: 
  • The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP ) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
  • Inspire Medical investors have until February 20, 2024 to file a lead plaintiff motion.
  • If you are a shareholder who suffered a loss, click here to participate.
  • On this news, Inspire Medical’s stock price fell $31.79, or 19.8%, to close at $129.65 per share on November 8, 2023, thereby injuring investors.

Inspire Medical Systems, Inc. (INSP) Stockholder Alert: Securities Law Firm Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Inspire Medical Systems, Inc. Class Action

Retrieved on: 
Tuesday, January 2, 2024
Obstructive sleep apnea, LLP, Person, SAN, News, Inspiration, INSP, OSA, Patient

Inspire Medical is a medical technology company that develops and commercializes minimally invasive products for patients with obstructive sleep apnea (“OSA”).

Key Points: 
  • Inspire Medical is a medical technology company that develops and commercializes minimally invasive products for patients with obstructive sleep apnea (“OSA”).
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • On November 7, 2023, Inspire Medical issued its results for the third quarter of 2023, acknowledging a decline in prior authorization submissions for patients seeking Inspire therapy.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Inspire Medical Systems, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.

Retrieved on: 
Tuesday, January 2, 2024
Obstructive sleep apnea, Food, Court, News, Complaint, Inspiration, Advertising, OSA, Action Replay, Patient, Sleep apnea, District court, Tobacco

If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.

Key Points: 
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Inspire Medical Systems, Inc. (INSP)

Retrieved on: 
Wednesday, December 27, 2023
Obstructive sleep apnea, LLP, Person, SAN, News, Inspiration, INSP, OSA, Patient

SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities who purchased of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023.

Key Points: 
  • SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities who purchased of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023.
  • Inspire Medical is a medical technology company that develops and commercializes minimally invasive products for patients with obstructive sleep apnea (“OSA”).
  • On November 7, 2023, Inspire Medical issued its results for the third quarter of 2023, acknowledging a decline in prior authorization submissions for patients seeking Inspire therapy.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Inspire Medical Systems, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

INSPIRE MEDICAL SYSTEMS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (NYSE: INSP)

Retrieved on: 
Tuesday, December 26, 2023
Obstructive sleep apnea, Food, Court, News, Complaint, Inspiration, Advertising, OSA, Action Replay, Patient, Sleep apnea, District court, Tobacco

Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).

Key Points: 
  • Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

INSPIRED ENTERTAINMENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspired Entertainment, Inc. on Behalf of Inspired Entertainment Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, December 25, 2023
Telephone, Bank statement, Inspiration, P.C, Audit committee, Software

NEW YORK, Dec. 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NASDAQ: INSE) on behalf of Inspired Entertainment stockholders.

Key Points: 
  • NEW YORK, Dec. 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NASDAQ: INSE) on behalf of Inspired Entertainment stockholders.
  • Our investigation concerns whether Inspired Entertainment has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On November 8, 2023, Inspired Entertainment, a gaming technology company, disclosed that the company did not comply with Generally Accepted Accounting Principles pertaining to the capitalization of its software.

Inspire Medical Systems, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, December 18, 2023
Inspiration, Conference, Patient, Obstructive sleep apnea

MINNEAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024.

Key Points: 
  • MINNEAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024.
  • Inspire is scheduled to present at 10:30 a.m. Eastern Time.
  • The presentation will be accessible via a live webcast here .

INSPIRED ENTERTAINMENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspired Entertainment, Inc. on Behalf of Inspired Entertainment Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, December 16, 2023
Telephone, Bank statement, Inspiration, P.C, Audit committee, Software

NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NASDAQ: INSE) on behalf of Inspired Entertainment stockholders.

Key Points: 
  • NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NASDAQ: INSE) on behalf of Inspired Entertainment stockholders.
  • Our investigation concerns whether Inspired Entertainment has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On November 8, 2023, Inspired Entertainment, a gaming technology company, disclosed that the company did not comply with Generally Accepted Accounting Principles pertaining to the capitalization of its software.